Get started
Author

Ming Jiang

Developing a Copper(II) Agent Based on His-146 and His-242 Residues of Human Serum Albumin Nanoparticles: Integration To Overcome Cisplatin Resistance and Inhibit the Metastasis of Nonsmall Cell Lung Cancer
2022 · Ming Jiang, Zhenlei Zhang, et al. · Journal of Medicinal Chemistry · 71
Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis
2020 · Juzheng Zhang, Zhenlei Zhang, et al. · Journal of Medicinal Chemistry · 50
Current status of iridium-based complexes against lung cancer
2022 · Tongfu Yang, Minghui Zhu, et al. · Frontiers in Pharmacology · 49
PDF
Developing a Novel Anticancer Gold(III) Agent to Integrate Chemotherapy and Immunotherapy
2021 · Juzheng Zhang, Ming Jiang, et al. · Journal of Medicinal Chemistry · 38
Developing a Novel Indium(III) Agent Based on Liposomes to Overcome Cisplatin-Induced Resistance in Breast Cancer by Multitargeting the Tumor Microenvironment Components
2021 · Ming Jiang, Yong Chu, et al. · Journal of Medicinal Chemistry · 37
Developing a Palladium(II) Agent to Overcome Multidrug Resistance and Metastasis of Liver Tumor by Targeted Multiacting on Tumor Cell, Inactivating Cancer-Associated Fibroblast and Activating Immune Response
2024 · Ming Jiang, Wenjuan Li, et al. · Journal of Medicinal Chemistry · 28
Recent development of Schiff-base metal complexes as therapeutic agents for lung cancer
2024 · Ming Jiang, Xiaoling Su, et al. · Journal of Molecular Structure · 28
Anticancer Activity and Mode of Action of Cu(II), Zn(II), and Mn(II) Complexes with 5-Chloro-2-N-(2-quinolylmethylene)aminophenol
2023 · Shuangshuang Gai, Liqin He, et al. · Molecules · 24
PDF
Human Serum Albumin-Based Dual-Agent Delivery Systems for Combination Therapy: Acting against Cancer Cells and Inhibiting Neovascularization in the Tumor Microenvironment
2020 · Zhenlei Zhang, Juzheng Zhang, et al. · Molecular Pharmaceutics · 24
Synthesis of a series of novel In( iii ) 2,6-diacetylpyridine bis(thiosemicarbazide) complexes: structure, anticancer function and mechanism
2020 · Shanhe Li, Muhammad Hamid Khan, et al. · Dalton Transactions · 20
Development of Cu(II) 4-hydroxybenzoylhydrazone complexes that induce mitochondrial DNA damage and mitochondria-mediated apoptosis in liver cancer
2024 · Ming Jiang, Qiwei Yan, et al. · Journal of Inorganic Biochemistry · 19
Development of a zinc( ii ) 2-pyridinecarboxaldehyde thiosemicarbazone complex with remarkable antitumor and antiangiogenic activities
2023 · Ming Jiang, Jinhui Pang, et al. · Dalton Transactions · 16
Lactoferrin Nanoparticle-Vanadium Complex: A Promising High-Efficiency Agent against Glioblastoma by Triggering Autophagy and Ferroptosis
2025 · Shuangshuang Gai, Qiwei Yan, et al. · Journal of Medicinal Chemistry · 14
Design an anticancer copper(II) pro-drug based on the flexible IIA subdomain of human serum albumin
2017 · Yao Zhang, Zhenlei Zhang, et al. · Journal of Inorganic Biochemistry · 14
Design of a novel Pt( ii ) complex to reverse cisplatin-induced resistance in lung cancer via a multi-mechanism
2022 · Ming Jiang, Tongfu Yang, et al. · Dalton Transactions · 13
Designing biotin-human serum albumin nanoparticles to enhance the targeting ability of binuclear ruthenium(III) compound
2020 · Ming Jiang, Shanhe Li, et al. · Journal of Inorganic Biochemistry · 10
Designing an anticancer Pd(II) complex as poly(ADP-ribose) polymerase 1 inhibitor
2025 · Shuangshuang Gai, Peng Cao, et al. · International Journal of Biological Macromolecules · 9
In vitro and In vivo anticancer activities of Bi(III) 2-thiazolecarboxaldehyde thiosemicarbazone complex
2024 · Xiaoying Jia, Jinhui Pang, et al. · Journal of Molecular Structure · 6
Designing a multitarget In( iii ) compound to overcome the resistance of lung cancer cells to cisplatin
2022 · Ming Jiang, Juzheng Zhang, et al. · Dalton Transactions · 6
Developing a Multitargeted Anticancer Bi-Copper(II)-Centered Thiocarbohydrazone Agent Based on Lys-199 and His-242 Residues in the IIA Subdomain of Human Serum Albumin
2026 · Shanhe Li, Xiaojun Wang, et al. · Journal of Medicinal Chemistry · 2
Benzothiazole hydrazone Cu(II) complex for therapeutic anticancer enhancement via PARP-1 inhibition
2026 · Ming Jiang, Xueyu Man, et al. · International Journal of Biological Macromolecules · 1
Development a stannum(IV) 8-quinolinecarbaldehyde thiosemicarbazone complex with remarkable anticancer activity via pyroptosis and apoptosis
2025 · Xiaoling Wu, Jinhui Pang, et al. · Journal of Molecular Structure · 1
Synthesis and Anticancer Studies of Pt(II) Complex Derived From 4‐Phenylthiosemicarbazone
2025 · Shuangshuang Gai, Lili Meng, et al. · Chemistry & Biodiversity · 1
PDF
Application of glycoconjugated metal complexes in cancer therapy
2026 · Xueyu Man, Anqun Su, et al. · European Journal of Medicinal Chemistry
CCDC 2031414: Experimental Crystal Structure Determination
2026 · Gai, Shuangshuang, Meng, Lili, et al. · The Cambridge Structural Database
Works count: 64
Citation count: 481
H-index: 14
I10-index: 16
Year
Topic
Type